Pure Global

Cimosir D Gemini High Sensitivity Reagent - Taiwan Registration 5d5b483306c731221f6ed52223a6a26b

Access comprehensive regulatory information for Cimosir D Gemini High Sensitivity Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5d5b483306c731221f6ed52223a6a26b and manufactured by INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5d5b483306c731221f6ed52223a6a26b
Registration Details
Taiwan FDA Registration: 5d5b483306c731221f6ed52223a6a26b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Cimosir D Gemini High Sensitivity Reagent
TW: ๅธŒๆ‘ฉ่ฅฟ็ˆพD้›™ๅญ้ซ˜ๆ•ๆ„Ÿๅบฆ่ฉฆๅŠ‘
Risk Class 2

Registration Details

5d5b483306c731221f6ed52223a6a26b

DHA00602431902

Company Information

Spain;;United States

Product Details

Automated latex-enhanced immunoassay for the quantitative detection of D-Dimer in human citrate plasma on the ACL TOP series system.

B Hematology, pathology, and genetics

B.7320 Fibrinogen/Fibrinolysis Product Analysis

Contract manufacturing;; input

Dates and Status

Jan 18, 2013

Jan 18, 2028